Inhalation Anesthetics Market Size and Share Analysis by Drug Type (Desflurane, Sevoflurane, Isoflurane), End User (Hospitals, Ambulatory Surgical Centers), Application (Induction, Maintenance)– Forecast to 2030

Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segment

1.4.1. Market size breakdown, by type

1.4.2. Market size breakdown, by end user

1.4.3. Market size breakdown, by application

1.4.4. Market size breakdown, by region

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Industry Outlook

4.1. Market Dynamics

4.1.1. Trends

4.1.2. Drivers

4.1.3. Restraints/challenges

4.1.4. Impact analysis of drivers/restraints

4.2. Impact of COVID-19

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining power of buyers

4.3.2. Bargaining power of suppliers

4.3.3. Threat of new entrants

4.3.4. Intensity of rivalry

4.3.5. Threat of substitutes

Chapter 5. Global Market

5.1. Overview

5.2. Market Revenue, by Type (2019–2030)

5.3. Market Revenue, by End User (2019–2030)

5.4. Market Revenue, by Application (2019–2030)

5.5. Market Revenue, by Region (2019–2030)

Chapter 6. North America Market

6.1. Overview

6.2. Market Revenue, by Type (2019–2030)

6.3. Market Revenue, by End User (2019–2030)

6.4. Market Revenue, by Application (2019–2030)

6.5. Market Revenue, by Country (2019–2030)

Chapter 7. Europe Market

7.1. Overview

7.2. Market Revenue, by Type (2019–2030)

7.3. Market Revenue, by End User (2019–2030)

7.4. Market Revenue, by Application (2019–2030)

7.5. Market Revenue, by Country (2019–2030)

Chapter 8. APAC Market

8.1. Overview

8.2. Market Revenue, by Type (2019–2030)

8.3. Market Revenue, by End User (2019–2030)

8.4. Market Revenue, by Application (2019–2030)

8.5. Market Revenue, by Country (2019–2030)

Chapter 9. LATAM Market

9.1. Overview

9.2. Market Revenue, by Type (2019–2030)

9.3. Market Revenue, by End User (2019–2030)

9.4. Market Revenue, by Application (2019–2030)

9.5. Market Revenue, by Country (2019–2030)

Chapter 10. MEA Market

10.1. Overview

10.2. Market Revenue, by Type (2019–2030)

10.3. Market Revenue, by End User (2019–2030)

10.4. Market Revenue, by Application (2019–2030)

10.5. Market Revenue, by Country (2019–2030)

Chapter 11. Competitive Landscape

11.1. List of Market Players and Their Offerings

11.2. Competitive Benchmarking of Key Players

11.3. Product Benchmarking of Key Players

11.4. Recent Strategic Developments

Chapter 12. Company Profiles

12.1. AbbVie Inc.

12.1.1. Business overview

12.1.2. Product and service offerings

12.1.3. Key financial summary

12.2. Baxter International Inc.

12.2.1. Business overview

12.2.2. Product and service offerings

12.2.3. Key financial summary

12.3. Piramal Enterprises Ltd.

12.3.1. Business overview

12.3.2. Product and service offerings

12.3.3. Key financial summary

12.4. Hikma Pharmaceuticals PLC

12.4.1. Business overview

12.4.2. Product and service offerings

12.4.3. Key financial summary

12.5. Halocarbon LLC

12.5.1. Business overview

12.5.2. Product and service offerings

12.5.3. Key financial summary

12.6. Lunan Pharmaceutical Group

12.6.1. Business overview

12.6.2. Product and service offerings

12.6.3. Key financial summary

12.7. Company 7

12.7.1. Business overview

12.7.2. Product and service offerings

12.7.3. Key financial summary

12.8. Company 8

12.8.1. Business overview

12.8.2. Product and service offerings

12.8.3. Key financial summary

12.9. Company 9

12.9.1. Business overview

12.9.2. Product and service offerings

12.9.3. Key financial summary

12.10. Company 10

12.10.1. Business overview

12.10.2. Product and service offerings

12.10.3. Key financial summary

12.11. Company 11

12.11.1. Business overview

12.11.2. Product and service offerings

12.11.3. Key financial summary

12.12. Company 12

12.12.1. Business overview

12.12.2. Product and service offerings

12.12.3. Key financial summary

12.13. Company 13

12.13.1. Business overview

12.13.2. Product and service offerings

12.13.3. Key financial summary

12.14. Company 14

12.14.1. Business overview

12.14.2. Product and service offerings

12.14.3. Key financial summary

12.15. Company 15

12.15.1. Business overview

12.15.2. Product and service offerings

12.15.3. Key financial summary

Chapter 13. Appendix

13.1. Abbreviations

13.2. Sources and References

13.3. Related Reports

 

LIST OF TABLES

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL INHALATION ANESTHETICS MARKET, BY TYPE, $M (2017–2022)

TABLE 5 GLOBAL INHALATION ANESTHETICS MARKET, BY TYPE, $M (2023–2026)

TABLE 6 GLOBAL INHALATION ANESTHETICS MARKET, BY TYPE, $M (2027–2030)

TABLE 7 GLOBAL INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2017–2022)

TABLE 8 GLOBAL INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2023–2026)

TABLE 9 GLOBAL INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2027–2030)

TABLE 10 GLOBAL INHALATION ANESTHETICS MARKET, BY END USER, $M (2017–2022)

TABLE 11 GLOBAL INHALATION ANESTHETICS MARKET, BY END USER, $M (2023–2026)

TABLE 12 GLOBAL INHALATION ANESTHETICS MARKET, BY END USER, $M (2027–2030)

TABLE 13 GLOBAL INHALATION ANESTHETICS MARKET, BY REGION, $M (2017–2022)

TABLE 14 GLOBAL INHALATION ANESTHETICS MARKET, BY REGION, $M (2023–2026)

TABLE 15 GLOBAL INHALATION ANESTHETICS MARKET, BY REGION, $M (2027–2030)

TABLE 16 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY TYPE, $M (2017–2022)

TABLE 17 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY TYPE, $M (2023–2026)

TABLE 18 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY TYPE, $M (2027–2030)

TABLE 19 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2017–2022)

TABLE 20 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2023–2026)

TABLE 21 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2027–2030)

TABLE 22 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY END USER, $M (2017–2022)

TABLE 23 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY END USER, $M (2023–2026)

TABLE 24 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY END USER, $M (2027–2030)

TABLE 25 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2017–2022)

TABLE 26 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2023–2026)

TABLE 27 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2027–2030)

TABLE 28 EUROPE INHALATION ANESTHETICS MARKET, BY TYPE, $M (2017–2022)

TABLE 29 EUROPE INHALATION ANESTHETICS MARKET, BY TYPE, $M (2023–2026)

TABLE 30 EUROPE INHALATION ANESTHETICS MARKET, BY TYPE, $M (2027–2030)

TABLE 31 EUROPE INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2017–2022)

TABLE 32 EUROPE INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2023–2026)

TABLE 33 EUROPE INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2027–2030)

TABLE 34 EUROPE INHALATION ANESTHETICS MARKET, BY END USER, $M (2017–2022)

TABLE 35 EUROPE INHALATION ANESTHETICS MARKET, BY END USER, $M (2023–2026)

TABLE 36 EUROPE INHALATION ANESTHETICS MARKET, BY END USER, $M (2027–2030)

TABLE 37 EUROPE INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2017–2022)

TABLE 38 EUROPE INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2023–2026)

TABLE 39 EUROPE INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2027–2030)

TABLE 40 APAC INHALATION ANESTHETICS MARKET, BY TYPE, $M (2017–2022)

TABLE 41 APAC INHALATION ANESTHETICS MARKET, BY TYPE, $M (2023–2026)

TABLE 42 APAC INHALATION ANESTHETICS MARKET, BY TYPE, $M (2027–2030)

TABLE 43 APAC INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2017–2022)

TABLE 44 APAC INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2023–2026)

TABLE 45 APAC INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2027–2030)

TABLE 46 APAC INHALATION ANESTHETICS MARKET, BY END USER, $M (2017–2022)

TABLE 47 APAC INHALATION ANESTHETICS MARKET, BY END USER, $M (2023–2026)

TABLE 48 APAC INHALATION ANESTHETICS MARKET, BY END USER, $M (2027–2030)

TABLE 49 APAC INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2017–2022)

TABLE 50 APAC INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2023–2026)

TABLE 51 APAC INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2027–2030)

TABLE 52 LATAM INHALATION ANESTHETICS MARKET, BY TYPE, $M (2017–2022)

TABLE 53 LATAM INHALATION ANESTHETICS MARKET, BY TYPE, $M (2023–2026)

TABLE 54 LATAM INHALATION ANESTHETICS MARKET, BY TYPE, $M (2027–2030)

TABLE 55 LATAM INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2017–2022)

TABLE 56 LATAM INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2023–2026)

TABLE 57 LATAM INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2027–2030)

TABLE 58 LATAM INHALATION ANESTHETICS MARKET, BY END USER, $M (2017–2022)

TABLE 59 LATAM INHALATION ANESTHETICS MARKET, BY END USER, $M (2023–2026)

TABLE 60 LATAM INHALATION ANESTHETICS MARKET, BY END USER, $M (2027–2030)

TABLE 61 LATAM INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2017–2022)

TABLE 62 LATAM INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2023–2026)

TABLE 63 LATAM INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2027–2030)

TABLE 64 MEA INHALATION ANESTHETICS MARKET, BY TYPE, $M (2017–2022)

TABLE 65 MEA INHALATION ANESTHETICS MARKET, BY TYPE, $M (2023–2026)

TABLE 66 MEA INHALATION ANESTHETICS MARKET, BY TYPE, $M (2027–2030)

TABLE 67 MEA INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2017–2022)

TABLE 68 MEA INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2023–2026)

TABLE 69 MEA INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2027–2030)

TABLE 70 MEA INHALATION ANESTHETICS MARKET, BY END USER, $M (2017–2022)

TABLE 71 MEA INHALATION ANESTHETICS MARKET, BY END USER, $M (2023–2026)

TABLE 72 MEA INHALATION ANESTHETICS MARKET, BY END USER, $M (2027–2030)

TABLE 73 MEA INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2017–2022)

TABLE 74 MEA INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2023–2026)

TABLE 75 MEA INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2027–2030)

TABLE 76 COMPANY 1 – AT A GLANCE

TABLE 77 COMPANY 1 – KEY FINANCIAL SUMMARY

TABLE 78 COMPANY 2 – AT A GLANCE

TABLE 79 COMPANY 2 – KEY FINANCIAL SUMMARY

TABLE 80 COMPANY 3 – AT A GLANCE

TABLE 81 COMPANY 3 – KEY FINANCIAL SUMMARY

TABLE 82 COMPANY 4 – AT A GLANCE

TABLE 83 COMPANY 4 – KEY FINANCIAL SUMMARY

TABLE 84 COMPANY 5 – AT A GLANCE

TABLE 85 COMPANY 5 – KEY FINANCIAL SUMMARY

TABLE 86 COMPANY 6 – AT A GLANCE

TABLE 87 COMPANY 6 – KEY FINANCIAL SUMMARY

TABLE 88 COMPANY 7 – AT A GLANCE

TABLE 89 COMPANY 7 – KEY FINANCIAL SUMMARY

TABLE 90 COMPANY 8 – AT A GLANCE

TABLE 91 COMPANY 8 – KEY FINANCIAL SUMMARY

TABLE 92 COMPANY 9 – AT A GLANCE

TABLE 93 COMPANY 9 – KEY FINANCIAL SUMMARY

TABLE 94 COMPANY 10 – AT A GLANCE

TABLE 95 COMPANY 10 – KEY FINANCIAL SUMMARY

TABLE 96 COMPANY 11 – AT A GLANCE

TABLE 97 COMPANY 11 – KEY FINANCIAL SUMMARY

TABLE 98 COMPANY 12 – AT A GLANCE

TABLE 99 COMPANY 12 – KEY FINANCIAL SUMMARY

TABLE 100 COMPANY 13 – AT A GLANCE

TABLE 101 COMPANY 13 – KEY FINANCIAL SUMMARY

TABLE 102 COMPANY 14 – AT A GLANCE

TABLE 103 COMPANY 14 – KEY FINANCIAL SUMMARY

TABLE 104 COMPANY 15 – AT A GLANCE

TABLE 105 COMPANY 15 – KEY FINANCIAL SUMMARY

 

LIST OF FIGURES

FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT

FIG 2 RESEARCH METHODOLOGY

FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION

FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE

FIG 6 DATA TRIANGULATION APPROACH

FIG 7 CURRENCY CONVERSION RATES FOR USD (2023)

FIG 8 GLOBAL INHALATION ANESTHETICS MARKET SUMMARY

FIG 9 BARGAINING POWER OF BUYERS

FIG 10 BARGAINING POWER OF SUPPLIERS

FIG 11 INTENSITY OF RIVALRY

FIG 12 THREAT OF NEW ENTRANTS

FIG 13 THREAT OF SUBSTITUTES

FIG 14 GLOBAL INHALATION ANESTHETICS MARKET SNAPSHOT

FIG 15 GLOBAL INHALATION ANESTHETICS MARKET, BY TYPE, $M (2019–2030)

FIG 16 GLOBAL INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2019–2030)

FIG 17 GLOBAL INHALATION ANESTHETICS MARKET, BY END USER, $M (2019–2030)

FIG 18 MAJOR WORLDWIDE MARKETS FOR INHALATION ANESTHETICS SOLUTIONS, $M

FIG 19 NORTH AMERICA INHALATION ANESTHETICS MARKET SNAPSHOT

FIG 20 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY TYPE, $M (2019–2030)

FIG 21 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2019–2030)

FIG 22 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY END USER, $M (2019–2030)

FIG 23 NORTH AMERICA INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2019–2030)

FIG 24 EUROPE INHALATION ANESTHETICS MARKET SNAPSHOT

FIG 25 EUROPE INHALATION ANESTHETICS MARKET, BY TYPE, $M (2019–2030)

FIG 26 EUROPE INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2019–2030)

FIG 27 EUROPE INHALATION ANESTHETICS MARKET, BY END USER, $M (2019–2030)

FIG 28 EUROPE INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2019–2030)

FIG 29 APAC INHALATION ANESTHETICS MARKET SNAPSHOT

FIG 30 APAC INHALATION ANESTHETICS MARKET, BY TYPE, $M (2019–2030)

FIG 31 APAC INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2019–2030)

FIG 32 APAC INHALATION ANESTHETICS MARKET, BY END USER, $M (2019–2030)

FIG 33 APAC INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2019–2030)

FIG 34 LATAM INHALATION ANESTHETICS MARKET SNAPSHOT

FIG 35 LATAM INHALATION ANESTHETICS MARKET, BY TYPE, $M (2019–2030)

FIG 36 LATAM INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2019–2030)

FIG 37 LATAM INHALATION ANESTHETICS MARKET, BY END USER, $M (2019–2030)

FIG 38 LATAM INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2019–2030)

FIG 39 MEA INHALATION ANESTHETICS MARKET SNAPSHOT

FIG 40 MEA INHALATION ANESTHETICS MARKET, BY TYPE, $M (2019–2030)

FIG 41 MEA INHALATION ANESTHETICS MARKET, BY APPLICATION, $M (2019–2030)

FIG 42 MEA INHALATION ANESTHETICS MARKET, BY END USER, $M (2019–2030)

FIG 43 MEA INHALATION ANESTHETICS MARKET, BY COUNTRY, $M (2019–2030)

FIG 44 COMPANY 1 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 45 COMPANY 2 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 46 COMPANY 3 – REVENUE SPLIT BY SOURCE AND GEOGRAPHY (2023)

FIG 47 COMPANY 4 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 48 COMPANY 5 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 49 COMPANY 6 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 50 COMPANY 7 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 51 COMPANY 8 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 52 COMPANY 9 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 53 COMPANY 10 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 54 COMPANY 11 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 55 COMPANY 12 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 56 COMPANY 13 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 57 COMPANY 14 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 58 COMPANY 15 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)